Brief report: the disability of chronic chikungunya arthritis

被引:0
作者
J. Kennedy Amaral
Joshua B. Bilsborrow
Robert T. Schoen
机构
[1] Federal University of Minas Gerais,Department of Infectious Diseases and Tropical Medicine
[2] Yale University School of Medicine,Section of Rheumatology, Allergy and Clinical Immunology
来源
Clinical Rheumatology | 2019年 / 38卷
关键词
Chronic chikungunya arthritis; Disability; Health Assessment Questionnaire Disability Index (HAQ-DI); Visual Analog Scale (VAS);
D O I
暂无
中图分类号
学科分类号
摘要
In 50% of patients, chikungunya fever (CHIKF) is followed by arthritic pain that is often chronic, painful, and disabling. To better define the spectrum of pain and disability in chronic CHIK arthritis (CCA), we evaluated 35 consecutive CCA patients seen in a Brazilian rheumatology clinic, using a pain Visual Analog Scale and the Health Assessment Questionnaire Disability Index. In our patients, pain and disability levels were of the same magnitude as are seen in other serious rheumatic diseases. The mean score for 19 patients with moderate disability was 1.42± 0.20 (median 1.37). The median HAQ-DI score for the entire group was 1.25. These findings underscore the morbidity imposed by CCA and the urgent need for improvements in management.
引用
收藏
页码:2011 / 2014
页数:3
相关论文
共 105 条
[11]  
Carpentier F(2018)Chikungunya in Brazil: rheumatologists on the front line J Rheumatol 45 1491-76
[12]  
Kassab S(2003)The Stanford health assessment questionnaire (HAQ): a review of its history, issues, progress, and documentation J Rheumatol 30 167-86
[13]  
Albert ML(2014)AB1071 the use of visual analogue scale in rheumatic disease: validation of an electronic version: table 1 Ann Rheum Dis 73 1155.2-210
[14]  
Lecuit M(1998)Predictors of functional disability in patients with rheumatoid arthritis Arthritis Care Res 11 346-97
[15]  
Michault A(2014)Review methods of evaluation of the quality of life in rheumatic diseases Reumatologia/Rheumatology 1 69-1340
[16]  
Yactoyo S(2011)Post-chikungunya chronic arthritis—our experience with DMARDs over two year follow up J Assoc Physicians India 59 83-1045
[17]  
Staples JE(2018)Rheumatic manifestations associated with chikungunya virus infection: a study of 307 patients with 32-month follow-up (RHUMATOCHIK study) Joint Bone Spine 85 207-1750
[18]  
Millot V(2008)Methotrexate and hydroxychloroquine combination therapy in chronic chikungunya arthritis: a 16 week study Indian J Rheumatol 3 93-undefined
[19]  
Cibrelus L(2016)Efficacy of combination DMARD therapy vs. hydroxychloroquine monotherapy in chronic persistent chikungunya arthritis: a 24-week randomized controlled open label study Clin Rheumatol 36 1335-undefined
[20]  
Pardo PR(2001)The burden of musculoskeletal diseases in the general population of Spain: results from a national survey Ann Rheum Dis 60 1040-undefined